塑造思想:关于结构化炼对精神分裂症谱系障碍的影响的系统综述和元分析
Elona Greca1, Valentina Belalcazar-Vivas1, Gerardo F Ferrer2
1Larkin Community Hospital, Miami, FL, United States.
Psychiatry research
|December 28, 2025
概括
结构化的运动显著改善了精神分裂症谱系障碍患者的福祉,认知和社会功能. 这种干预提供了超越标准精神病治疗的实质性好处,提高了整体生活质量.
科学领域:
- 精神病学和神经科学 精神病学和神经科学
- 运动科学 运动科学
- 康复医学 康复医学 康复医学
背景情况:
- 精神分裂症谱系障碍与认知,生活质量和社会功能显著受损有关.
- 结构化的运动干预措施显示出改善这些多方面的结果的潜力.
- 这项研究研究了有氧运动和联合运动对认知功能,症状严重程度和幸福感的影响.
研究的目的:
- 系统地审查和分析结构化炼对精神分裂症谱系障碍患者的影响.
- 评估运动对认知功能,症状严重程度,生活质量和社会功能的影响.
- 探索运动效益的潜在调节者 (年龄,性别) 和调解者 (BDNF,炎症).
主要方法:
- 在多个数据库 (PubMed,EMBASE,PsycINFO等) 中以PRISMA为指导的系统搜索. 在2009年至2024年期间进行.
- 包括17个随机对照试验,并使用随机效应模型进行元分析,以计算标准化平均差异 (SMD).
- 偏见的风险,出版偏见和证据的确定性是使用既有方法 (RoB 2,Egger的测试,GRADE) 进行评估的.
主要成果:
- 结构化炼在整体幸福感 (SMD = 0.68),认知 (SMD = 0.59),症状严重程度 (SMD = 0.71),生活质量 (SMD = 0.60) 和社会功能 (SMD = 0.55) 中表现出中等到大的改善.
- 在多个领域观察到显著的益处,表明运动具有强大的效果.
- 年龄和性别适度的影响,在男性和36-45岁的人群中发现的益处更大. 机械洞察力表明,BDNF增加和减少炎症是潜在的调解者.
结论:
- 结构化炼是一种有效的辅助治疗精神分裂症谱系障碍,增强精神和功能结果.
- 研究结果支持将个性化,可扩展的炼计划整合到常规精神病治疗计划中.
- 运动干预是一种有希望的非药物治疗方法,可以改善患者的治疗结果和生活质量.
关键词:
有氧和抵抗训练和抵抗训练大脑衍生神经营养因子 (BDNF)在精神分裂症的认知功能.提高生活质量,改善生活质量.随机对照试验是随机对照试验.精神分裂症谱系障碍 精神分裂症谱系障碍提高社会功能 增强社会功能结构化的运动干预措施.减轻症状的严重程度,减轻症状的严重程度.更多相关视频
08:48Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
Published on: January 29, 2016
17.2K
06:00A Rehabilitation Program of Exoskeleton-assisted Body Weight-Supported Treadmill Training with Non-immersive Virtual Reality for Stroke Patients
Published on: May 16, 2025
922
相关概念视频
Biological Causes of Schizophrenia
458
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
458
Drug Therapy
229
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
229
Schizophrenia
673
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
673
Negative and Cognitive Symptoms of Schizophrenia
394
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
394
